
Caradon Therapeutics, Inc. has raised $559K in total funding. The most recent round was Pre-Seed.
Caradon Therapeutics, Inc. is headquartered in Encinitas, CA.
Cardiometabolic diseases in humans and companion animals need better, disease-modifying treatment options.
Caradon Therapeutics develops long-acting, disease-modifying peptide-based therapeutics to treat cardiometabolic diseases.
They say they use a proprietary technology to modify peptide agonists specifically to make them long-acting, built on stated extensive experience developing peptide-based biotech therapies.
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated August 26, 2026.